MCK Relative Valuation - Mckesson Corp

Watchlist Manager

Watchlist

Price: 736.2 EUR -1% Market Closed

Market Cap: €91.6B

M	Mckesson Corp F:MCK	US
	Major Drilling Group International Inc TSX:MDI	CA
	Deezer SA PAR:DEEZR	FR

Multiples-Based Value

MCK price has not been updated for more than 2 years. This may indicate that the stock has been delisted.

The Multiples-Based Value of one MCK stock under the Base Case scenario is 1 378.44 EUR. Compared to the current market price of 736.2 EUR, Mckesson Corp is Undervalued by 47%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is relative valuation?

How is Multiples-Based Value calculated?

MCK Multiples-Based Value

Base Case

Undervaluation 47%

Multiples-Based Value

Price €736.2

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
US		Mckesson Corp F:MCK	105.4B EUR	0.3	24.5	17.3	19.4
US		Cencora Inc NYSE:COR	62.4B USD	0.2	38.7	13.7	17.3
US	A	Amerisourcebergen Corp LSE:0HF3	62.3B USD	0.2	38.3	13.6	17.1
US		Cardinal Health Inc NYSE:CAH	50.2B USD	0.2	30.5	14.7	19.2
AU		Sigma Healthcare Ltd ASX:SIG	30.7B AUD	2.7	33.8	25.1	25.1
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	64.1B CNY	0.2	11.2	8.7	8.7
CN		Huadong Medicine Co Ltd SZSE:000963	63B CNY	1.5	17	13.2	13.2
US		Henry Schein Inc NASDAQ:HSIC	8.5B USD	0.7	22	10.9	15.3
CN		Sinopharm Group Co Ltd HKEX:1099	65.3B HKD	0.1	8.2	0.7	0.9
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	12.2T KRW	5.9	89.6	59.9	61.9
AU	E	EBOS Group Ltd OTC:EBOSY	7.7B USD	0.9	48.7	32.1	32.1

				Revenue Growth	P/S to Growth
US		Mckesson Corp F:MCK	Average P/S: 1.2 0.3	10%	0
US		Cencora Inc NYSE:COR	0.2	8%	0
US	A	Amerisourcebergen Corp LSE:0HF3	0.2	8%	0
US		Cardinal Health Inc NYSE:CAH	0.2	11%	0
AU		Sigma Healthcare Ltd ASX:SIG	2.7	30%	0.1
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	0.2	7%	0
CN		Huadong Medicine Co Ltd SZSE:000963	1.5	7%	0.2
US		Henry Schein Inc NASDAQ:HSIC	0.7	4%	0.2
CN		Sinopharm Group Co Ltd HKEX:1099	0.1	5%	0
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	5.9	18%	0.3
AU	E	EBOS Group Ltd OTC:EBOSY	0.9	7%	0.1

				Earnings Growth	PEG
US		Mckesson Corp F:MCK	Average P/E: 33 24.5	24%	1
US		Cencora Inc NYSE:COR	38.7	40%	1
US	A	Amerisourcebergen Corp LSE:0HF3	38.3	40%	1
US		Cardinal Health Inc NYSE:CAH	30.5	25%	1.2
AU		Sigma Healthcare Ltd ASX:SIG	33.8	24%	1.4
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	11.2	N/A	N/A
CN		Huadong Medicine Co Ltd SZSE:000963	17	12%	1.4
US		Henry Schein Inc NASDAQ:HSIC	22	24%	0.9
CN		Sinopharm Group Co Ltd HKEX:1099	8.2	N/A	N/A
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	89.6	42%	2.1
AU	E	EBOS Group Ltd OTC:EBOSY	48.7	12%	4.1

				EBITDA Growth	EV/EBITDA to Growth
US		Mckesson Corp F:MCK	Average EV/EBITDA: 19.1 17.3	17%	1
US		Cencora Inc NYSE:COR	13.7	9%	1.5
US	A	Amerisourcebergen Corp LSE:0HF3	13.6	9%	1.5
US		Cardinal Health Inc NYSE:CAH	14.7	14%	1.1
AU		Sigma Healthcare Ltd ASX:SIG	25.1	28%	0.9
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	8.7	N/A	N/A
CN		Huadong Medicine Co Ltd SZSE:000963	13.2	17%	0.8
US		Henry Schein Inc NASDAQ:HSIC	10.9	7%	1.6
CN		Sinopharm Group Co Ltd HKEX:1099	0.7	N/A	N/A
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	59.9	32%	1.9
AU	E	EBOS Group Ltd OTC:EBOSY	32.1	20%	1.6

				EBIT Growth	EV/EBIT to Growth
US		Mckesson Corp F:MCK	Average EV/EBIT: 20.9 19.4	20%	1
US		Cencora Inc NYSE:COR	17.3	15%	1.2
US	A	Amerisourcebergen Corp LSE:0HF3	17.1	15%	1.1
US		Cardinal Health Inc NYSE:CAH	19.2	19%	1
AU		Sigma Healthcare Ltd ASX:SIG	25.1	27%	0.9
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	8.7	8%	1.1
CN		Huadong Medicine Co Ltd SZSE:000963	13.2	11%	1.2
US		Henry Schein Inc NASDAQ:HSIC	15.3	15%	1
CN		Sinopharm Group Co Ltd HKEX:1099	0.9	26%	0
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	61.9	38%	1.6
AU	E	EBOS Group Ltd OTC:EBOSY	32.1	10%	3.2

Mckesson Corp
F:MCK

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

MCK Competitors Multiples
Mckesson Corp Competitors

See Also

Company

Help

Tools

Stocks

Mckesson Corp F:MCK

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

MCK Competitors Multiples Mckesson Corp Competitors

See Also

Company

Help

Tools

Stocks

Mckesson Corp
F:MCK

MCK Competitors Multiples
Mckesson Corp Competitors